ariceptXR

Citigroup has released its Pfizer, Inc. (NYSE: PFE) core product trends for the week ending 10/15/2010. Lipitor, Lyrica, Chantix and AriceptXR are among the drugs featured in the report. “We arrive at our $17 target price for Pfizer based on a relative P/E compared to the US Drug peer group,”...

Citigroup has issued a report on Pfizer's (NYSE: PFE) product trends for the week ending on 9/24. In the report, Citigroup writes "Lipitor NRx/TRx Share Was 21.5%(-5bps)/22.0%(-15bps). Lipitor YOY TRx's have declined -12% YTD. PFE took 5% & 6.9% price increases(PI's) on 7/1/10 & 1/1/10...